Who Owns Damora Therapeutics Stock?
NASDAQ: DMRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 105.78%
- Institutions (% of float)
- 115.52%
- Held by insiders
- 8.43%
- Institutional holders
- 153
- Institutions 91.6%
- Insiders 8.4%
- Public and other 0.0%
Who owns Damora Therapeutics stock?
Institutional investors own about 105.8% of Damora Therapeutics's shares, spread across 153 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 8.43% of DMRA.
The largest institutional holders are Price (T.Rowe) Associates Inc (0.08%), Gamma Investing LLC (0.00%) and Harbour Investments, Inc. (0.00%). Together, the top 5 institutions control 0.1% of shares outstanding. In their latest filings, 5 of the top 5 institutions increased their DMRA positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of DMRA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Price (T.Rowe) Associates Inc | 48.74K | 0.08% | +100.0% |
| Gamma Investing LLC | 91 | 0.00% | +100.0% |
| Harbour Investments, Inc. | 40 | 0.00% | +100.0% |
| Farther Finance Advisors, Llc | 40 | 0.00% | +100.0% |
| Rothschild Investment LLC | 34 | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of DMRA
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1.84M | 2.97% |
| iShares Trust-iShares Russell 2000 ETF | 1.34M | 2.18% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 834.04K | 1.35% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 754.69K | 1.22% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 583.68K | 0.95% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 540.25K | 0.88% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 500.00K | 0.81% |
| Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund | 454.90K | 0.74% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 454.56K | 0.74% |
| Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund | 410.18K | 0.66% |
Frequently asked questions
Who is the largest shareholder of Damora Therapeutics?
Price (T.Rowe) Associates Inc is the largest institutional shareholder of DMRA, owning 0.08% of shares outstanding (48.74K shares) as of its latest 13F filing.
What percentage of Damora Therapeutics is owned by institutions?
Institutions own about 105.8% of DMRA shares and 115.5% of the public float.
How much of Damora Therapeutics do insiders own?
Insiders, such as officers and directors, own about 8.43% of DMRA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.